Shares of both companies plunged following the announcement, which comes less than a year after Tempus acquired ...

Key Points Interested in Tempus AI, Inc.? Here are five stocks we like better. Tempus AI plans to acquire Personalis to ...

Mayo Clinic's Center for Individualized Medicine and genomic sequencing specialist Tempus announced a collaboration to provide personalized treatment for cancer patients based on analytics and machine ...

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry ...

AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. Tempus said the acquisition will help the ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an ...

Check out the latest Tempus Ai Inc (TEM) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Great news for Tempus AI stock! The company has just received FDA approval for an upgraded version of its Tempus Pixel platform — a cardiac imaging system that uses advanced AI to deliver highly ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 3, Tempus AI, Inc. (NASDAQ:TEM) reported that it launched an open-source digital pathology ...

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. During the first ...

View Tempus AI, Inc. Class A TEM stock quote prices, financial information, real-time forecasts, and company news from CNN.